» Authors » Peter Goldstraw

Peter Goldstraw

Explore the profile of Peter Goldstraw including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 122
Citations 10579
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Rami-Porta R, Wittekind C, Goldstraw P
J Thorac Oncol . 2020 Oct; 15(12):1815-1818. PMID: 33067147
No abstract available.
3.
Lim E, Sousa I, Shah P, Diggle P, Goldstraw P
Ann Thorac Surg . 2020 Jan; 109(5):1496-1501. PMID: 31891694
Background: The largest randomised controlled trial evaluating results of lung volume reduction surgery (LVRS) was conducted by the National Emphysema Treatment Trial (NETT) that published a series of reports for...
4.
Goldstraw P
J Thorac Dis . 2018 Oct; 10(Suppl 22):S2576-S2579. PMID: 30345092
No abstract available.
5.
Rice T, Ishwaran H, Ferguson M, Blackstone E, Goldstraw P
J Thorac Oncol . 2016 Nov; 12(1):36-42. PMID: 27810391
This primer for eighth edition staging of esophageal and esophagogastric epithelial cancers presents separate classifications for the clinical (cTNM), pathologic (pTNM), and postneoadjuvant pathologic (ypTNM) stage groups, which are no...
6.
Osarogiagbon R, Smeltzer M, Faris N, Rami-Porta R, Goldstraw P, Asamura H
J Thorac Oncol . 2016 Sep; 11(10):1612-4. PMID: 27663398
No abstract available.
7.
Rami-Porta R, Asamura H, Brierley J, Goldstraw P
J Thorac Oncol . 2016 Jul; 11(8):1201-1203. PMID: 27453163
No abstract available.
8.
Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt W, et al.
J Thorac Oncol . 2016 Jan; 11(1):39-51. PMID: 26762738
The IASLC Staging and Prognostic Factors Committee has collected a new database of 94,708 cases donated from 35 sources in 16 countries around the globe. This has now been analysed...
9.
Asamura H, Chansky K, Crowley J, Goldstraw P, Rusch V, Vansteenkiste J, et al.
J Thorac Oncol . 2015 Dec; 10(12):1675-84. PMID: 26709477
Introduction: Nodal status is considered to be one of the most reliable indicators of the prognosis in patients with lung cancer and thus is indispensable in determining the optimal therapeutic...
10.
Eberhardt W, Mitchell A, Crowley J, Kondo H, Kim Y, Turrisi 3rd A, et al.
J Thorac Oncol . 2015 Nov; 10(11):1515-22. PMID: 26536193
Introduction: The aim of this study is to analyze all metastatic (M) categories of the current tumor, node, and metastasis (TNM) classification of lung cancer with the objective of providing...